This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Patry, C. Articles by Chabot, B. Search for Related Content PubMed PubMed Citation Articles by Patry, C. Articles by Chabot, B.

Small Interfering RNA-Mediated Reduction in Heterogeneous Nuclear Ribonucleoparticule A1/A2 Proteins Induces Apoptosis in Human Cancer Cells but not in Normal Mortal Cell Lines

Département de Microbiologie et d’Infectiologie. Faculté de Médecine, Université de Sherbrooke, Sherbrooke, Québec, Canada

To prevent their recognition as DNA breaks, the ends of linear chromosomes are organized into telomeres, which are made of proteins bound to telomere-specific, double-stranded repeats and to single-stranded DNA extensions, the G-tails. The mammalian heterogeneous nuclear ribonucleoparticule A1 and A2 proteins can bind with high affinity to such G-tails. Moreover, previous work established that in certain mouse cells a severe reduction in the level of A1 is associated with shortened telomeric repeat tracts, and restoring A1 expression increases telomere length. Here, we document that the expression of A1/A2 proteins is elevated in a variety of human cancers, whereas A1/A2 expression is lower or absent in normal tissues. To determine whether the status of A1/A2 proteins could be improved from cancer markers to cancer targets, we used small interfering RNA-mediated RNA interference to elicit a reduction in A1/A2 proteins in a variety of human cell lines. We show that this treatment provoked specific and rapid cell death by apoptosis in cell lines derived from cervical, colon, breast, ovarian, and brain cancers. Cancer cell lines that lack p53 or express a defective p53 protein were equally sensitive to a small interfering RNA-mediated decrease in A1/A2 expression. The reduction in A1/A2 levels in HeLa cells was associated with a change in the distribution of the lengths of G-tails, an event not observed when apoptosis was induced with staurosporine. Remarkably, comparable decreases in the expression of A1/A2 in several mortal human fibroblastic and epithelial cell lines did not promote cell death. Thus, manipulating the level and activity of A1/A2 proteins may constitute a potent and specific approach in the treatment of human cancers of various origins.

This article has been cited by other articles:

				T. Nagata, Y. Takada, A. Ono, K. Nagata, Y. Konishi, T. Nukina, M. Ono, A. Matsugami, A. Furukawa, N. Fujimoto, et al. Elucidation of the mode of interaction in the UP1-telomerase RNA-telomeric DNA ternary complex which serves to recruit telomerase to telomeric DNA and to enhance the telomerase activity Nucleic Acids Res., December 1, 2008; 36(21): 6816 - 6824. [Abstract] [Full Text] [PDF]

				J. P. Venables, C.-S. Koh, U. Froehlich, E. Lapointe, S. Couture, L. Inkel, A. Bramard, E. R. Paquet, V. Watier, M. Durand, et al. Multiple and Specific mRNA Processing Targets for the Major Human hnRNP Proteins Mol. Cell. Biol., October 1, 2008; 28(19): 6033 - 6043. [Abstract] [Full Text] [PDF]

				A. Cammas, F. Pileur, S. Bonnal, S. M. Lewis, N. Leveque, M. Holcik, and S. Vagner Cytoplasmic Relocalization of Heterogeneous Nuclear Ribonucleoprotein A1 Controls Translation Initiation of Specific mRNAs Mol. Biol. Cell, December 1, 2007; 18(12): 5048 - 5059. [Abstract] [Full Text] [PDF]

				S. A. Akker, S. Misra, S. Aslam, E. L. Morgan, P. J. Smith, B. Khoo, and S. L. Chew Pre-Spliceosomal Binding of U1 Small Nuclear Ribonucleoprotein (RNP) and Heterogenous Nuclear RNP E1 Is Associated with Suppression of a Growth Hormone Receptor Pseudoexon Mol. Endocrinol., October 1, 2007; 21(10): 2529 - 2540. [Abstract] [Full Text] [PDF]

				A. Baguet, S. Degot, N. Cougot, E. Bertrand, M.-P. Chenard, C. Wendling, P. Kessler, H. Le Hir, M.-C. Rio, and C. Tomasetto The exon-junction-complex-component metastatic lymph node 51 functions in stress-granule assembly J. Cell Sci., August 15, 2007; 120(16): 2774 - 2784. [Abstract] [Full Text] [PDF]

				C. S. Kim, S. K. Seol, O.-K. Song, J. H. Park, and S. K. Jang An RNA-Binding Protein, hnRNP A1, and a Scaffold Protein, Septin 6, Facilitate Hepatitis C Virus Replication J. Virol., April 15, 2007; 81(8): 3852 - 3865. [Abstract] [Full Text] [PDF]

				S. Guil, J. C. Long, and J. F. Caceres hnRNP A1 Relocalization to the Stress Granules Reflects a Role in the Stress Response Mol. Cell. Biol., August 1, 2006; 26(15): 5744 - 5758. [Abstract] [Full Text] [PDF]

				Q.-S. Zhang, L. Manche, R.-M. Xu, and A. R. Krainer hnRNP A1 associates with telomere ends and stimulates telomerase activity RNA, June 1, 2006; 12(6): 1116 - 1128. [Abstract] [Full Text] [PDF]

				N. Li, R. Guo, W. Li, J. Shao, S. Li, K. Zhao, X. Chen, N. Xu, S. Liu, and Y. Lu A proteomic investigation into a human gastric cancer cell line BGC823 treated with diallyl trisulfide Carcinogenesis, June 1, 2006; 27(6): 1222 - 1231. [Abstract] [Full Text] [PDF]

				Y. He, M. A. Brown, J. A. Rothnagel, N. A. Saunders, and R. Smith Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation J. Cell Sci., July 15, 2005; 118(14): 3173 - 3183. [Abstract] [Full Text] [PDF]

				D. Garneau, T. Revil, J.-F. Fisette, and B. Chabot Heterogeneous Nuclear Ribonucleoprotein F/H Proteins Modulate the Alternative Splicing of the Apoptotic Mediator Bcl-x J. Biol. Chem., June 17, 2005; 280(24): 22641 - 22650. [Abstract] [Full Text] [PDF]

				K. Moran-Jones, L. Wayman, D. D. Kennedy, R. R. Reddel, S. Sara, M. J. Snee, and R. Smith hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere Nucleic Acids Res., January 19, 2005; 33(2): 486 - 496. [Abstract] [Full Text] [PDF]

				C. Patry, B. Lemieux, R. J. Wellinger, and B. Chabot Targeting heterogeneous nuclear ribonucleoparticule A1 and A2 proteins by RNA interference promotes cell death in transformed but not in normal mouse cell lines Mol. Cancer Ther., October 1, 2004; 3(10): 1193 - 1199. [Abstract] [Full Text] [PDF]